Order Article Reprints

Kim C, Xi L, Cultraro CM, Wei F, Jones G, Cheng J, Shafiei A, Pham TH-T, Roper N, Akoth E, et al. Longitudinal Circulating Tumor DNA Analysis in Blood and Saliva for Prediction of Response to Osimertinib and Disease Progression in EGFR-Mutant Lung Adenocarcinoma. Cancers. 2021; 13(13):3342. https://doi.org/10.3390/cancers13133342

Kim, Chul, Liqiang Xi, Constance M. Cultraro, Fang Wei, Gregory Jones, Jordan Cheng, Ahmad Shafiei, Trinh Hoc-Tran Pham, Nitin Roper, Elizabeth Akoth, and et al. 2021. "Longitudinal Circulating Tumor DNA Analysis in Blood and Saliva for Prediction of Response to Osimertinib and Disease Progression in EGFR-Mutant Lung Adenocarcinoma" Cancers 13, no. 13: 3342. https://doi.org/10.3390/cancers13133342

Kim, C., Xi, L., Cultraro, C. M., Wei, F., Jones, G., Cheng, J., Shafiei, A., Pham, T. H.-T., Roper, N., Akoth, E., Ghafoor, A., Misra, V., Monkash, N., Strom, C., Tu, M., Liao, W., Chia, D., Morris, C., Steinberg, S. M., ... Guha, U. (2021). Longitudinal Circulating Tumor DNA Analysis in Blood and Saliva for Prediction of Response to Osimertinib and Disease Progression in EGFR-Mutant Lung Adenocarcinoma. Cancers, 13(13), 3342. https://doi.org/10.3390/cancers13133342